We are live on
!
Find out more
MWNA
Marshall Wace North America Portfolio holdings
AUM
$23.5B
1-Year Est. Return
46.46%
This Fund
S&P 500
This Quarter
Est. Return
+10.61%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.7B
AUM Growth
+$3.14B
(+18%)
Cap. Flow
+$1.47B
Cap. Flow
% of AUM
7.1%
Top 10 Holdings %
Top 10 Hldgs %
15.76%
Holding
1,778
New
496
Increased
377
Reduced
371
Closed
524
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCA Healthcare
HCA
|
+$221M |
| 2 |
GoDaddy
GDDY
|
+$159M |
| 3 |
Cigna
CI
|
+$135M |
| 4 |
Pfizer
PFE
|
+$132M |
| 5 |
HOLX
Hologic
HOLX
|
+$98.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$156M |
| 2 |
Apple
AAPL
|
+$148M |
| 3 |
Microsoft
MSFT
|
+$126M |
| 4 |
McDonald's
MCD
|
+$121M |
| 5 |
Danaher
DHR
|
+$107M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.95% |
| 2 | Technology | 21.4% |
| 3 | Consumer Discretionary | 12.43% |
| 4 | Industrials | 11.77% |
| 5 | Financials | 6.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
HealthStream
HSTM
$840M
| $85K | ﹤0.01% |
3,136
-7,847
| -71% | -$216K |
|
|
CYBE
1077
DELISTED
Cyberoptics Corp
CYBE
| $85K | ﹤0.01% |
4,662
-1,852
| -28% | -$31.5K |
|
1078
WaFd
WAFD
$2.75B
| $84K | ﹤0.01% |
+2,305
| New | +$84.6K |
|
1079
Fulton Financial
FULT
$4.64B
| $83K | ﹤0.01% |
+4,750
| New | +$80.7K |
|
1080
Lennox International
LII
$15.2B
| $83K | ﹤0.01% |
341
-23,532
| -99% | -$5.84M |
|
1081
CF Industries
CF
$17.3B
| $82K | ﹤0.01% |
1,719
-116,391
| -99% | -$5.45M |
|
1082
Navient
NAVI
$853M
| $82K | ﹤0.01% |
+6,008
| New | +$80.9K |
|
1083
Tactile Systems Technology
TCMD
$665M
| $82K | ﹤0.01% |
+1,208
| New | +$66.8K |
|
|
BXG
1084
DELISTED
Bluegreen Vacations Corporation Common Stock
BXG
| $81K | ﹤0.01% |
7,845
+5,566
| +244% | +$54.7K |
|
1085
Allegion
ALLE
$14.4B
| $80K | ﹤0.01% |
+644
| New | +$74.3K |
|
1086
Atlantic Union Bankshares
AUB
$5.97B
| $80K | ﹤0.01% |
+2,139
| New | +$80.5K |
|
|
TWOU
1087
DELISTED
2U Inc
TWOU
| $80K | ﹤0.01% |
+111
| New | +$69K |
|
|
PTE
1088
DELISTED
PolarityTE, Inc. Common Stock
PTE
| $80K | ﹤0.01% |
1,212
+149
| +14% | +$10.7K |
|
1089
Griffon
GFF
$4.86B
| $79K | ﹤0.01% |
3,906
-48,435
| -93% | -$1.02M |
|
|
ALBO
1090
DELISTED
Albireo Pharma Inc
ALBO
| $79K | ﹤0.01% |
+3,104
| New | +$62.1K |
|
|
WCC
1091
WESCO International
WCC
$17.7B
| $78K | ﹤0.01% |
1,311
-8,609
| -87% | -$449K |
|
1092
Magna International
MGA
$18.8B
| $77K | ﹤0.01% |
1,400
-74,700
| -98% | -$4.05M |
|
1093
Grupo Aeroportuario del Sureste
ASR
$8.3B
| $76K | ﹤0.01% |
+404
| New | +$68.6K |
|
1094
Fossil Group
FOSL
$318M
| $76K | ﹤0.01% |
+9,591
| New | +$88.5K |
|
1095
Innospec
IOSP
$2.28B
| $73K | ﹤0.01% |
705
-112
| -14% | -$10.7K |
|
|
KW
1096
DELISTED
Kennedy-Wilson Holdings
KW
| $73K | ﹤0.01% |
+3,283
| New | +$73.6K |
|
1097
Old National Bancorp
ONB
$10.2B
| $73K | ﹤0.01% |
+3,979
| New | +$71.4K |
|
1098
STMicroelectronics
STM
$50B
| $72K | ﹤0.01% |
+2,668
| New | +$63.1K |
|
1099
Transcat
TRNS
$871M
| $72K | ﹤0.01% |
+2,274
| New | +$69.2K |
|
1100
Autohome
ATHM
$2.62B
| $71K | ﹤0.01% |
+884
| New | +$68.8K |
|
Similar funds
TGHSA
PAM
HB
MWA
3SCA
HFCIV
DVC
NAM
Marshall Wace North America's Q4 2019 Portfolio in Review
As of Q4 2019, Marshall Wace North America held 1,778 positions worth $20.7B, up 18% from $17.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace North America deployed $1.47B of net new capital in Q4 2019, opening 496 new positions and adding to 377 existing holdings. Its largest new stake was Deere & Co: 519,053 shares worth $89.9M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Gilead Sciences, an estimated $156M trimmed.
- Marshall Wace North America's largest Q4 2019 buy was Deere & Co: 519,053 shares worth $89.9M.
- Marshall Wace North America added most to HCA Healthcare in Q4 2019, an estimated $221M increase.
- Marshall Wace North America's biggest Q4 2019 reduction was Gilead Sciences, cutting an estimated $156M.
- Marshall Wace North America fully exited McDonald's in Q4 2019, selling an estimated $121M.
- Marshall Wace North America's ten largest holdings make up 16% of its $20.7B portfolio in Q4 2019.
- Marshall Wace North America opened 496 new positions and closed 524 in Q4 2019.
- Marshall Wace North America's portfolio value rose 18% quarter-over-quarter to $20.7B.
Based on Marshall Wace North America's 13F filing for Q4 2019, filed 14 Feb 2020.